These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 21122661)
21. Plasma lipoprotein(a) levels and LDL-cholesterol lowering response to statin therapy in patients with heterozygous familial hypercholesterolemia. Miltiadous G; Saougos V; Cariolou M; Elisaf MS Ann Clin Lab Sci; 2006; 36(3):353-5. PubMed ID: 16951279 [TBL] [Abstract][Full Text] [Related]
22. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. John S; Schneider MP; Delles C; Jacobi J; Schmieder RE Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218 [TBL] [Abstract][Full Text] [Related]
23. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity. Castro PF; Miranda R; Verdejo HE; Greig D; Gabrielli LA; Alcaino H; Chiong M; Bustos C; Garcia L; Mellado R; Vukasovic JL; Godoy I; Lavandero S J Heart Lung Transplant; 2008 Apr; 27(4):435-41. PubMed ID: 18374881 [TBL] [Abstract][Full Text] [Related]
24. Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment. Vuorio A; Raal F; Kaste M; Kovanen PT Atherosclerosis; 2021 Mar; 320():53-60. PubMed ID: 33540179 [TBL] [Abstract][Full Text] [Related]
25. Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study. Fuentes F; Alcala-Diaz JF; Watts GF; Alonso R; Muñiz O; Díaz-Díaz JL; Mata N; Sanchez Muñoz-Torrero JF; Brea Á; Galiana J; Figueras R; Aguado R; Piedecausa M; Cepeda JM; Vidal JI; Rodríguez-Cantalejo F; López-Miranda J; Mata P; Int J Cardiol; 2015 Dec; 201():79-84. PubMed ID: 26296047 [TBL] [Abstract][Full Text] [Related]
26. [Organprotection in cardiac risk patients--rational of perioperative beta-adrenoceptor-antagonists and statins]. Hanss R; Bein B Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Apr; 45(4):246-52; quiz 253. PubMed ID: 20387182 [TBL] [Abstract][Full Text] [Related]
28. White matter hyperintensities on T2-weighted MRI images among DNA-verified older familial hypercholesterolemia patients. Hyttinen L; Autti T; Rauma S; Soljanlahti S; Vuorio AF; Strandberg TE Acta Radiol; 2009 Apr; 50(3):320-6. PubMed ID: 19229678 [TBL] [Abstract][Full Text] [Related]
29. Increased levels of atherosclerosis markers in salt-sensitive hypertension. Larrousse M; Bragulat E; Segarra M; Sierra C; Coca A; de La Sierra A Am J Hypertens; 2006 Jan; 19(1):87-93. PubMed ID: 16461197 [TBL] [Abstract][Full Text] [Related]
30. Statins and familial hypercholesterolaemia. Neil A; Humphries SE BMJ; 2009 Jan; 338():a3041. PubMed ID: 19158168 [No Abstract] [Full Text] [Related]
31. C-reactive protein in patients with familial hypercholesterolemia: no effect of simvastatin therapy. Mohrschladt MF; de Maat MP; Westendorp RG; Smelt AH Atherosclerosis; 2001 Aug; 157(2):491-4. PubMed ID: 11472751 [TBL] [Abstract][Full Text] [Related]
32. Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Ito MK; McGowan MP; Moriarty PM; J Clin Lipidol; 2011 Jun; 5(3 Suppl):S38-45. PubMed ID: 21600528 [No Abstract] [Full Text] [Related]
33. Optimal Treatment using Statins from Childhood in Heterozygous Familial Hypercholesterolemia. Nohara A J Atheroscler Thromb; 2016; 23(1):39-43. PubMed ID: 26370454 [No Abstract] [Full Text] [Related]
34. Combination of intracerebral haemorrhage and familial hypercholesterolemia in the acute hospital setting--a challenge for statin treatment? Vuorio A; Kaste M; Kovanen PT Int J Stroke; 2015 Jun; 10(4):467-8. PubMed ID: 25973703 [TBL] [Abstract][Full Text] [Related]
37. Diagnosis and treatment of familial hypercholesterolemia: The impact of recent guidelines. Palma L; Welding M; OʼShea J Nurse Pract; 2016 Aug; 41(8):36-43. PubMed ID: 27414814 [TBL] [Abstract][Full Text] [Related]
38. Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia. Canepa M; Artom N; Ameri P; Carbone F; Montecucco F; Ghigliotti G; Brunelli C; Dallegri F; Pende A; Pisciotta L Int J Cardiol; 2018 Mar; 255():215-220. PubMed ID: 29290422 [No Abstract] [Full Text] [Related]
39. Diagnosis and Management of Individuals With Heterozygous Familial Hypercholesterolemia: Too Late and Too Little. Hovingh GK; Kastelein JJ Circulation; 2016 Sep; 134(10):710-2. PubMed ID: 27601557 [No Abstract] [Full Text] [Related]
40. Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients. Holm T; Andreassen AK; Ueland T; Kjekshus J; Frøland SS; Kjekshus E; Simonsen S; Aukrust P; Gullestad L Am J Cardiol; 2001 Mar; 87(6):815-8, A9. PubMed ID: 11249916 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]